Fig. 8
From: Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
Development of two nomograms combining DEIRG-based signature and independent prognostic clinical variables to predict OS and PFS in sarcoma patients. a Nomogram of OS combining the OS signature and three clinical variables of sarcoma patients. (b-d) Calibration curves of the nomogram at 1, 2, and 3 years. (e) Nomogram of PFS combining the PFS signature and two clinical variables of sarcoma patients. In the two nomograms, a patient example marked in sky-blue is shown. (f–h) Calibration curves of the nomogram at 1, 2, and 3 years. DEIRGs Differentially expressed immune-related genes, OS Overall survival, PFS Progression-free survival